Drug Delivery Systems

news

QA of prostaglandin analogues for glaucoma treatment

11 November 2022 | By Caroline Peachey (European Pharmaceutical Review)

Paper highlights trends in developing analytical procedures to assess the quality of prostaglandin analogues used to treat glaucoma.

article

Putting complex medicines under the microscope

10 November 2022 | By Isabel Peset (Medicines Discovery Catapult), Lorna Fitzpatrick (Medicines Discovery Catapult), Martin Main (Medicines Discovery Catapult)

The biological characterisation of complex medicines like nucleic acid therapeutics and antibody-drug conjugates is important to understand their biodistribution and cellular delivery. Here, Isabel Peset, Lorna FitzPatrick and Martin Main from Medicines Discovery Catapult discuss the potential for using advanced light microscopy techniques.

news

Microneedle patches designed by AI restore hair in balding mice

1 November 2022 | By Izzy Wood (European Pharmaceutical Review)

Using AI, researchers have produced a nanozyme treatment for regenerating hair in mice, delivered via a microneedle.

news

Robotic capsule could replace injected biologics

13 October 2022 | By Catherine Eckford (European Pharmaceutical Review)

MIT researchers have developed a robotic capsule that tunnels through mucus in the GI tract to deliver large oral protein-based drugs like insulin.

news

Mass producing biodegradable stem cell therapy microrobots

29 September 2022 | By Catherine Eckford (European Pharmaceutical Review)

Korean researchers developed ground-breaking new technology that manufactured biodegradable microrobots intended for targeted precision therapies at a rate of 100 per minute.

news

GM herpes virus fights advanced cancers

26 September 2022 | By Catherine Eckford (European Pharmaceutical Review)

A Phase I trial showed early potential in using a genetically engineered herpes virus to combat advanced cancers that exhibited no response to immunotherapies.

video

On-demand webinar: Effective contamination control strategy

26 September 2022 | By Charles River

Discover the significance of accurate microbial identifications in building an effective contamination control strategy to keep up with the latest regulatory requirements.

webinar

Addressing analytical control challenges for different plasmid DNA products

16 September 2022 | By GenScript ProBio

Learn how to develop an analytical control strategy for different plasmid DNA product applications with GenScript ProBio, a global CDMO in cell and gene therapy industry.

whitepaper

Whitepaper: Annual PQR: A thing of the past

1 September 2022 | By Caliber Technologies

Anytime PQR is the new way of generating APQR by automating the reports anytime in 3 easy steps. Now make the entire process system driven with CaliberAPQR.

news

3D printing of starch-based tablets for personalised drug delivery

31 August 2022 | By Caroline Peachey (European Pharmaceutical Review)

Drug release could be tailored by adapting the type of starch used and the tablet shape, highlighting the promise of 3D printing for future personalised drug delivery applications.

article

Managing the next pandemic: the role of nasal vaccine administration

30 August 2022 | By Joe Neale (Recipharm)

In this article, Recipharm’s Joe Neale explores how learnings from the COVID-19 pandemic can be applied in the future and asks how nasal administration could help our fight against tomorrow’s outbreaks.

article

Actualising the power of antibody-drug conjugates as cancer therapeutics

24 August 2022 | By Dominik Schumacher (Tubulis), Jonas Helma-Smets (Tubulis)

Antibody-drug conjugates (ADCs) are designed to be highly-targeted therapies with the potential to maximise the potency of a treatment while reducing unwanted side effects on healthy tissues. Some 20 years after the first ADC product approval, Dominik Schumacher and Jonas Helma-Smets of Tubulis GmbH discuss how improved and optimised technologies…

article

European Pharmaceutical Review Issue 4 2022

24 August 2022 | By European Pharmaceutical Review

In EPR Issue 4, experts discuss implementing a global strategy to improve the sustainability of endotoxin testing, how to accelerate timelines for manufacture of multi-specific antibodies and the potential of oncolytic viruses as a therapy for glioblastoma. Also featured: progress towards smart vaccine manufacturing, an update on edible anticounterfeiting technology,…

news

Take a look inside drug delivery devices

23 August 2022 | By Hannah Balfour (European Pharmaceutical Review)

Explore the internal workings of two of the most common drug delivery devices - the powder asthma inhaler and the EpiPen®.

news

L9LS antibody safe and highly protective against malaria, finds study

5 August 2022 | By Hannah Balfour (European Pharmaceutical Review)

Phase I human challenge study shows a single subcutaneous injection of the monoclonal antibody L9LS provides at least short-term protection against malaria.